MFG
REGN icon

Magnus Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Magnus Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-928
Closed -$589K – 392
2025
Q1 		$589K Sell
928
-213
-19% -$147K 0.06% 199
2024
Q4 		$813K Sell
1,141
-447
-28% -$375K 0.08% 167
2024
Q3 		$1.67M Buy
1,588
+20
+1% +$22.3K 0.17% 103
2024
Q2 		$1.65M Buy
1,568
+1
+0.1% +$969 0.19% 95
2024
Q1 		$1.51M Buy
1,567
+8
+0.5% +$7.61K 0.18% 99
2023
Q4 		$1.37M Buy
1,559
+3
+0.2% +$2.47K 0.18% 94
2023
Q3 		$1.28M Buy
1,556
+150
+11% +$118K 0.19% 87
2023
Q2 		$1.01M Sell
1,406
-110
-7% -$84.8K 0.14% 110
2023
Q1 		$1.25M Buy
1,516
+15
+1% +$11.3K 0.19% 93
2022
Q4 		$1.08M Sell
1,501
-6
-0.4% -$4.43K 0.18% 96
2022
Q3 		$1.04M Buy
1,507
+492
+48% +$310K 0.2% 91
2022
Q2 		$600K Buy
1,015
+16
+2% +$10.4K 0.11% 138
2022
Q1 		$698K Buy
999
+14
+1% +$8.86K 0.12% 134
2021
Q4 		$622K Buy
985
+37
+4% +$22.7K 0.12% 121
2021
Q3 		$574K Buy
948
+35
+4% +$21.7K 0.12% 116
2021
Q2 		$510K Buy
913
+170
+23% +$86.1K 0.11% 125
2021
Q1 		$352K Sell
743
-202
-21% -$98.3K 0.09% 159
2020
Q4 		$457K Sell
945
-622
-40% -$336K 0.05% 156
2020
Q3 		$877K Sell
1,567
-107
-6% -$64.9K 0.1% 78
2020
Q2 		$1.04M Buy
1,674
+694
+71% +$394K 0.12% 68
2020
Q1 		$479K Sell
980
-322
-25% -$133K 0.07% 151
2019
Q4 		$489K Buy
+1,302
New +$438K 0.07% 151
2019
Q3 		– Sell
-1,386
Closed -$434K – 578
2019
Q2 		$434K Buy
1,386
+482
+53% +$160K 0.08% 136
2019
Q1 		$371K Buy
904
+18
+2% +$7.41K 0.08% 163
2018
Q4 		$331K Buy
+886
New +$324K 0.09% 156

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Magnus Financial Group's REGN Position: Q2 2025 in Review

Magnus Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 928 shares — an estimated $589K sold.

Magnus Financial Group first reported a position in REGN in Q4 2018 and held it in 25 quarters. The position peaked at $1.67M in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Magnus Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Magnus Financial Group sold 928 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $589K.
  • Magnus Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 25 quarters.
  • Magnus Financial Group's Regeneron Pharmaceuticals position peaked at $1.67M in Q3 2024.
  • 1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Magnus Financial Group's 13F filing for Q2 2025, filed 16 Jul 2025.